Results 141 to 150 of about 7,268 (227)
MDM2 and MDMX are oncogenic homologue proteins that regulate the activity and stability of p53, a tumor suppressor protein involved in more than 50% of human cancers.
Nicola Giacchè (1871518) +5 more
core +1 more source
Multiple modes of Mdmx regulation affect p53 activation
MDMX has emerged as a negative regulator of p53 transcriptional activity following DNA damage, loss of ribosomal integrity, and aberrant mitogenic signaling.
Gilkes, Daniele M., Gilkes, Daniele M
core
MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation. [PDF]
Zhang M +11 more
europepmc +1 more source
Targeting the Undruggable: Deep Learning-Driven Design of Peptide Therapeutics in Cancer. [PDF]
Nguyen HTN +4 more
europepmc +1 more source
Computational alanine scanning with GBSA and interaction entropy: a review of methodologies and applications in protein-protein and protein-ligand binding. [PDF]
Liu X, Xu X, Duan LL, Zhang JZH.
europepmc +1 more source
RING finger E3 ubiquitin ligases: novel therapeutic opportunities in melanoma. [PDF]
Zhang JF +7 more
europepmc +1 more source
The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway. [PDF]
Brown AL, Lian X, Wang Q.
europepmc +1 more source
Completed clinical trials of p53-targeted therapeutic strategies in cancer: A cross-sectional ClinicalTrials.gov registry analysis. [PDF]
Alorfi NM, Alourfi NM.
europepmc +1 more source

